So A - Search Results

1

Optimizing intravesical mitomycin C therapy in non-muscle-invasive bladder cancer.

Zargar H, Aning J, Ischia J, So A, Black P. Zargar H, et al. Among authors: so a. Nat Rev Urol. 2014 Apr;11(4):220-30. doi: 10.1038/nrurol.2014.52. Epub 2014 Mar 11. Nat Rev Urol. 2014. PMID: 24619373 Review.

2

Prognostic markers in muscle invasive bladder cancer.

Tiguert R, Lessard A, So A, Fradet Y. Tiguert R, et al. Among authors: so a. World J Urol. 2002 Aug;20(3):190-5. doi: 10.1007/s00345-002-0279-y. Epub 2002 Jun 7. World J Urol. 2002. PMID: 12196903 Review.

3

Synergistic antitumor activity by combined treatment with gemcitabine and antisense oligodeoxynucleotide targeting clusterin gene in an intravesical administration model against human bladder cancer kotcc-1 cells.

Miyake H, Eto H, Hara I, So A, Li D, Gleave ME. Miyake H, et al. Among authors: so a. J Urol. 2004 Jun;171(6 Pt 1):2477-81. doi: 10.1097/01.ju.0000118382.89456.f7. J Urol. 2004. PMID: 15126879

4

Antisense oligonucleotide therapy in the management of bladder cancer.

So A, Rocchi P, Gleave M. So A, et al. Curr Opin Urol. 2005 Sep;15(5):320-7. doi: 10.1097/01.mou.0000175572.46986.2c. Curr Opin Urol. 2005. PMID: 16093856 Review.

5

A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging.

Hadaschik BA, Black PC, Sea JC, Metwalli AR, Fazli L, Dinney CP, Gleave ME, So AI. Hadaschik BA, et al. Among authors: so ai. BJU Int. 2007 Dec;100(6):1377-84. doi: 10.1111/j.1464-410X.2007.07165.x. Epub 2007 Sep 10. BJU Int. 2007. PMID: 17850390

6

Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.

Hadaschik BA, Adomat H, Fazli L, Fradet Y, Andersen RJ, Gleave ME, So AI. Hadaschik BA, et al. Among authors: so ai. Clin Cancer Res. 2008 Mar 1;14(5):1510-8. doi: 10.1158/1078-0432.CCR-07-4475. Clin Cancer Res. 2008. PMID: 18316576 Clinical Trial.

7

Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.

Hadaschik BA, Jackson J, Fazli L, Zoubeidi A, Burt HM, Gleave ME, So AI. Hadaschik BA, et al. Among authors: so ai. BJU Int. 2008 Aug 5;102(5):610-6. doi: 10.1111/j.1464-410X.2008.07669.x. Epub 2008 Apr 2. BJU Int. 2008. PMID: 18384625

8

Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.

Hadaschik BA, ter Borg MG, Jackson J, Sowery RD, So AI, Burt HM, Gleave ME. Hadaschik BA, et al. Among authors: so ai. BJU Int. 2008 Jun;101(11):1347-55. doi: 10.1111/j.1464-410X.2008.07571.x. Epub 2008 Apr 2. BJU Int. 2008. PMID: 18384637

9

Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.

Hadaschik BA, Zhang K, So AI, Fazli L, Jia W, Bell JC, Gleave ME, Rennie PS. Hadaschik BA, et al. Among authors: so ai. Cancer Res. 2008 Jun 15;68(12):4506-10. doi: 10.1158/0008-5472.CAN-08-0238. Cancer Res. 2008. PMID: 18559493

10

[Oncolytic vesicular stomatitis viruses as intravesical agents against non-muscle-invasive bladder cancer].

Hadaschik BA, Zhang K, So AI, Bell JC, Thüroff JW, Rennie PS, Gleave ME. Hadaschik BA, et al. Among authors: so ai. Urologe A. 2008 Sep;47(9):1145-51. doi: 10.1007/s00120-008-1827-x. Urologe A. 2008. PMID: 18670747 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

801 results

Search Page

Filters